Search

everythinglearnresearchcommunity

for

Search:↓

The methods accurately measured brain androgens, showing most 5α-androstane-3α,17β-diol comes from outside the brain, while androsterone is both transported and made in the brain.

New anti-acne medications are being tested to offer alternatives to current treatments.

Most antiandrogen treatments effectively reduce acne in hyperandrogenic women, but finasteride is the least effective.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Prostaglandin E2 collagen matrix may help stimulate hair growth.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Lower allopregnanolone levels increase stress-related dopamine release in the brain.

Hair loss in women can be treated with hormone therapy.

The Potts-Guy model best predicts skin permeability for the tested drugs.

Treating prolactinoma doesn't significantly affect hirsutism or cause high androgen levels.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Compound 15a was effective in inhibiting 5α-reductase.

Bimatoprost eye drops can cause temporary eyelid changes and may help with hair growth research.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

A new lipid-based formula using myristyl myristate can improve estradiol treatment for hair loss.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Flutamide reduces hair growth better but has more side effects.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

11-oxyandrogens are linked to excess hair growth in PCOS, but don't help diagnose it.

Cyproterone acetate was effective in treating acne, hirsutism, and alopecia with few side effects.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Cyproterone acetate works similarly to other treatments for hirsutism, but more research is needed.

Finasteride causes reproductive malformations in male rats.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.